MEDICENNA THERAPEUTICS CORP (MDNA.CA) Stock Balance Sheet
Canada - TSX:MDNA - CA58490H1073 - Common Stock
1 CAD
0 (0%)
| MRQ (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 20.46M | 24.84M | 16.98M | 33.60M | 20.54M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 1.17M | 2.69M | 1.16M | 860.00K | 1.31M | |||
| Other Current Assets | 947.00K | 639.00K | 931.00K | 1.93M | 1.55M | |||
| Total Current Assets | 22.58M | 28.17M | 19.08M | 36.39M | 23.39M | |||
| Non-Current Assets | ||||||||
| PPE Net | 142.00K | 159.00K | N/A | N/A | 0.00 | |||
| Intangibles | 50.00K | 52.00K | 57.00K | 60.00K | 70.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 192.00K | 211.00K | 57.00K | 60.00K | 70.00K | |||
| TOTAL ASSETS | 22.77M | 28.38M | 19.13M | 36.45M | 23.46M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 58.00K | 49.00K | N/A | N/A | 0.00 | |||
| Accrued Expenses | 1.33M | 1.69M | 793.00K | 2.18M | 950.00K | |||
| Accounts Payable | 3.19M | 2.70M | 2.07M | 1.62M | 1.67M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 4.57M | 4.43M | 2.86M | 3.80M | 2.62M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 104.00K | 119.00K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 3.45M | 4.73M | 11.08M | 3.16M | N/A | |||
| Total Non-Current Liabilities | 3.56M | 4.85M | 11.08M | 3.16M | 0.00 | |||
| TOTAL LIABILITIES | 8.13M | 9.29M | 13.94M | 6.96M | 2.62M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -123.18M | -118.25M | -106.45M | -80.98M | -70.93M | |||
| Additional Paid In Capital | 11.56M | 21.05M | 10.70M | 9.49M | 7.93M | |||
| Common Shares | 126.23M | 116.30M | 100.92M | 100.92M | 83.67M | |||
| Other Shareholders' Equity | 35.00K | 3.00K | 19.00K | 60.00K | 170.00K | |||
| Shares Outstanding | 83.38M | 78.22M | 69.64M | 69.64M | 55.65M | |||
| Tangible Book Value per Share | 0.17 | 0.24 | 0.07 | 0.42 | 0.37 | |||
| Total Shareholders' Equity | 14.64M | 19.09M | 5.19M | 29.49M | 20.84M | |||
| TOTAL LIABILITIES AND EQUITY | 22.77M | 28.38M | 19.13M | 36.45M | 23.46M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | N/A | N/A | N/A | |||
| Current Ratio | 4.94 | 6.35 | 6.66 | 9.58 | 8.93 | |||
| Return On Assets (ROA) | -57.51% | -41.59% | -133.09% | -27.57% | -96.25% | |||
| Return On Equity (ROE) | -89.45% | -61.82% | -490.58% | -34.08% | -108.35% | |||
All data in CAD , ROIC based on taxRate of 0.28